Skip to main content

Published locations for FDA issues CRL for IV formulation of antiemetic agent

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA issues CRL for IV formulation of antiemetic agent

User login

  • Reset your password
  • /content/fda-issues-crl-iv-formulation-antiemetic-agent
  • /hematology-oncology/article/186921/leukemia-myelodysplasia-transplantation/fda-issues-crl-iv-formulation
  • /hematologytimes/article/186921/leukemia-myelodysplasia-transplantation/fda-issues-crl-iv-formulation